14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
SNDA vs HCSG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Healthcare Services Group (HCSG) is the stronger overall head-to-head candidate over Sonida Senior Living, Inc. (SNDA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). SNDA carries a Unified Composite Score of 37.2/100 (SELL) at $32.23 (57.1x Forward P/E, -3.1% operating margin), whereas HCSG carries 45.3/100 (HOLD) at $24.63 (19.8x Forward P/E, 6.1% operating margin).
Growth vs. Quality Trade-Off: HCSG earns the overall head-to-head edge with a stronger Unified Composite Score (45.3/100 HOLD vs. SNDA 37.2/100 SELL) and 0.59β · 60% Vol risk profile, whereas SNDA leads top-line expansion (+131.2% YoY revenue growth, 2.04x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: SNDA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.9); meanwhile HCSG trades in a Markup technical trend (CONSOLIDATION options phase, RSI 55.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SNDA vs HCSG. Trailing 12-month operating profitability (SNDA -3.1% vs HCSG 6.1%) and valuation multiples (SNDA 57.1x vs HCSG 19.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Care Facilities value chain with $1.7B market capitalization and 6.1% operating margin.
OpEx & R&D Reinvestment10.0% of Rev ($188M)
90D Engineering Disclosures0 Published
Investor FAQ SNDA vs HCSG Key Questions & Quantitative Answers
As of Nov 17, 2026, Healthcare Services Group (HCSG) is the stronger overall head-to-head candidate over Sonida Senior Living, Inc. (SNDA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). SNDA carries a Unified Composite Score of 37.2/100 (SELL) at $32.23 (57.1x Forward P/E, -3.1% operating margin), whereas HCSG carries 45.3/100 (HOLD) at $24.63 (19.8x Forward P/E, 6.1% operating margin). Growth vs. Quality Trade-Off: HCSG earns the overall head-to-head edge with a stronger Unified Composite Score (45.3/100 HOLD vs. SNDA 37.2/100 SELL) and 0.59β · 60% Vol risk profile, whereas SNDA leads top-line expansion (+131.2% YoY revenue growth, 2.04x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: SNDA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.9); meanwhile HCSG trades in a Markup technical trend (CONSOLIDATION options phase, RSI 55.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SNDA leads the Growth & Scale pillar: SNDA posts +131.2% YoY revenue growth and -21.7% YoY earnings growth on $594M TTM revenue (29.4% gross margin, -3.1% operating margin), compared with HCSG at +3.3% YoY revenue growth and -39.0% YoY earnings growth on $1.88B TTM revenue (16.1% gross margin, 6.1% operating margin). On trailing 12-month operating scale, SNDA generates $594M in USD-normalized revenue versus $1.88B for HCSG. In operating R&D and SG&A reinvestment, SNDA deploys 32.5% of Rev ($193M) (0 90-day corporate R&D disclosures) versus 10.0% of Rev ($188M) (0 disclosures) for HCSG.
HCSG screens cheaper on headline valuation multiples. SNDA trades at 57.1x Forward P/E, 57.1x Trailing P/E, 2.04x PEG, and 2.7x EV/Revenue (17.3% EBITDA margin), whereas HCSG trades at 19.8x Forward P/E, 16.8x Trailing P/E, 2.39x PEG, and 0.8x EV/Revenue (5.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SNDA (-27.0% ROE) versus HCSG (20.4% ROE) capital efficiency.
In options market volatility and institutional positioning, SNDA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 48% Vol realized risk). By comparison, HCSG carries 52.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.59β · 60% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.